Find Post Investigations On:
Facebook Scribd Twitter
Friendfeed RSS Google Reader
» About This Blog | Meet the Investigative Team | Subscribe
Ongoing Investigation

Top Secret America

The Post explores the top secret world the government created in response to the attacks of Sept. 11.

Ongoing Investigation

The Hidden Life of Guns

How guns move through American society, from store counter to crime scene.

Have a Tip?

Talk to Us

If you have solid tips, news or documents on potential ethical violations or abuses of power, we want to know. Send us your suggestions.
• E-mail Us

Categories

Post Investigations
In-depth investigative news
and multimedia from The Washington Post.
• Special Reports
• The Blog

Reporters' Notebook
An insider's guide to investigative news: reporters offer insights on their stories.

The Daily Read
A daily look at investigative news of note across the Web.

Top Picks
A weekly review of the best
in-depth and investigative reports from across the nation.

Hot Documents
Court filings, letters, audits and other documents of interest.

D.C. Region
Post coverage of investigative news in Maryland, Virginia and the District.

Washington Watchdogs
A periodic look into official government investigations.

Help! What Is RSS?
Find out how to follow Post Investigations in your favorite RSS reader.

Hot Comments

Unfortunately I believe that we are limited in what we can focus on. I think that if we proceed with the partisan sideshow of prosecuting Bush admin. officials, healthcare will get lost in the brouhaha.
— Posted by denamom, Obama's Quandary...

Recent Posts
Bob Woodward

The Washington Post's permanent investigative unit was set up in 1982 under Bob Woodward.


Archives
See what you missed, find what you're looking for.
Blog Archive »
Investigations Archive »

Have a Tip?
Send us information on ethics violations or abuses of power.
E-Mail Us »

Other
Investigations
Notable investigative projects from other news outlets.
On the Web »
Top Picks »

Nigeria and Pfizer Near Deal on Child Deaths

POSTED: 03:27 PM ET, 04/ 3/2009 by The Editors


Anas Mustapha, a Nigerian child believed to have been subjected to a Pfizer drug trial during the '96 meningitis epidemic, now suffers brain damage. (George Osodi / AP File 2007)

More than eight years after The Washington Post investigated a clinical drug trial carried out by Pfizer Inc. in Nigeria, the pharmaceutical giant appears to have reached a general agreement to settle charges that the company acted illegally.

The Nigerian state of Kano had filed civil and criminal cases alleging that Pfizer illegally tested the experimental drug Trovan on gravely ill children during a 1996 meningitis epidemic. Eleven children died in the trial and others were permanently disabled.

A Pfizer lawyer and the Kano state attorney general said today that they had reached a broad agreement. Nigerian lawyers close to the negotiations told The Post that Pfizer has asked for a number of conditions, the specifics of which remain undisclosed. Lawyers said a target sum of $75 million had been discussed in recent days.

Pfizer has long asserted that the 1996 clinical study was conducted with the approval of the Nigerian government and the consent of the participants' parents or guardians. The trial violated no international or Nigerian laws, the company said.

The Post articles in 2000 found that Pfizer carried out the experiment on 200 children at a makeshift epidemic camp in the northern Nigerian town of Kano. The articles reported that Pfizer had no signed consent forms for the children and relied on a falsified ethics approval letter to defend the design of the experiment.

Trovan was never approved for use by American children. The Food and Drug Administration approved it for adults in 1998 but later severely restricted its use after reports of liver failure. The European Union banned the drug in 1999.

By The Editors |  April 3, 2009; 3:27 PM ET
Previous: Blagojevich, Brothers Indicted; Geithner Fell Short at NY Fed; New Rule May Revalue Toxic Assets | Next: Summers Earned $5.2M From Hedge Fund; Madoff Complaint Implicates Aide; Pfizer Settles Drug-Trial Case

Comments

Please email us to report offensive comments.



Post a Comment

We encourage users to analyze, comment on and even challenge washingtonpost.com's articles, blogs, reviews and multimedia features.

User reviews and comments that include profanity or personal attacks or other inappropriate comments or material will be removed from the site. Additionally, entries that are unsigned or contain "signatures" by someone other than the actual author will be removed. Finally, we will take steps to block users who violate any of our posting standards, terms of use or privacy policies or any other policies governing this site. Please review the full rules governing commentaries and discussions.




characters remaining

 
 

© 2010 The Washington Post Company